Project Grant K23AI199607
- Federal Project Grant Award Summary Baylor College of Medicine received a $461,187 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period April 1, 2026 through March 31, 2028. The award supports a one health epidemiological investigation into the molecular epidemiology and transmission dynamics of leishmaniasis in Texas, focusing on two major metropolitan areas: Houston and...
- Federal Grant Award Summary Baylor College of Medicine received a $160,500 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded August 8, 2025, with a completion date of July 31, 2027. The grant funds development and validation of a novel TC-24 Enzyme-Linked Immunosorbent Assay (ELISA) test to evaluate post-treatment efficacy for Chagas disease, a neglected tropical disease endemic...
- Federal Project Grant Award Summary The University of Texas Health Science Center at Houston received a $568,909 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective August 1, 2025, through July 30, 2030. This award funds research establishing a comprehensive framework for understanding and predicting viral dynamics at the community level by integrating wastewater-based...
- Federal Grant Award Summary Award Details: Funding Agency: National Institute of Allergy and Infectious Diseases (NIAID) Federal Grant Program: Allergy and Infectious Diseases Research (CFDA 93.855) Awardee: Baylor College of Medicine, Houston, TX Total Obligation: $371,141.00 Award Date: August 6, 2025 Project Period: August 6, 2025 – July 31, 2030 Project Description: Baylor College of Medicine will develop, deploy, and evaluate the Fundamentals in Bioinformatics (FUNINBIO) continuing...
- Federal Grant Award Summary Baylor College of Medicine received a $451,956 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective August 15, 2025 through July 31, 2027. This award supports the development and application of novel in vitro models to investigate the pathogenic mechanisms by which Treponema pallidum (the causative agent of syphilis) invades the placenta and causes...
- Federal Project Grant Award Summary William Marsh Rice University received a $421,673 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded on July 24, 2025, with a completion date of June 30, 2027. The award supports the development of foundational computational tools and laboratory methods to identify and detect signature regions of antimicrobial resistant pathogens for wastewater...
- Federal Project Grant Award Summary Baylor College of Medicine received a $454,288 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective August 1, 2025 through July 31, 2027. The award funds research investigating the immune function of the RNA helicase DDX6, specifically examining how this protein regulates hematopoietic stem cell (HSC) maintenance, quiescence, and immune...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Methodist Hospital Research Institute a Project Grant of $444,125 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on August 8, 2025, with a completion date of July 31, 2027. This research project will characterize a previously unknown intercellular signaling pathway in Group B Streptococcus (GBS) and determine its contribution to bacterial pathogenesis. Specifically,...
- Federal Project Grant Award Summary Baylor College of Medicine received a $160,500 Project Grant award from the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective August 1, 2025, through July 31, 2027. The grant funds the development of a Rickettsia species isolate library derived from tick specimens collected in Texas and Belize. The primary deliverables include establishment of a curated bank of Rickettsia...
- Federal Grant Award Summary Baylor College of Medicine received a $200,625 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded May 5, 2026, with completion targeted for April 30, 2028. The research project, "Unraveling Vector Ecology and Genomic Drivers of Vertical Transmission: Defining Relapsing Fever Borrelia Persistence in Populations of the Under-Studied Argasid Tick,...
Baylor College of Medicine received a $191,219 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective June 2, 2026, with a completion date of May 31, 2031. The award supports an epidemiological assessment of Strongyloides stercoralis infection in at-risk populations in the Greater Houston metropolitan area. The research will deliver two primary products: (1) prevalence data and risk-factor analysis of chronic strongyloidiasis among patients seeking healthcare at a safety-net hospital system in Houston, Texas, and (2) wastewater-based epidemiological surveillance data identifying geographic areas with S. stercoralis presence in the region. The grant leverages innovative wastewater-based epidemiology methodology to detect and characterize strongyloidiasis—a neglected tropical disease that often remains asymptomatic but can cause severe morbidity when disseminated in immunocompromised hosts. By combining traditional epidemiological study with wastewater surveillance, the research aims to inform public health efforts for timely detection and treatment of at-risk populations, addressing a significant gap in disease surveillance for a condition likely underdiagnosed due to its asymptomatic presentation. Performance of the award is conducted in Houston, Texas.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $191.2k | 6/3/26 |